Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib

The prognostic and predictive value of pre-treatment serum levels of carcinoembryonic antigen (CEA) and cytokeratin-19 fragments (CYFRA 21-1) were assessed in advanced non-small cell lung cancer (NSCLC) patients treated with gefitinib or erlotinib. Pre-treatment CEA and CYFRA 21-1 levels were measur...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: JUNG, MINKYU, KIM, SE HYUN, LEE, YOUNG JOO, HONG, SOOJUNG, KANG, YOUNG AE, KIM, SE KYU, CHANG, JOON, RHA, SUN YOUNG, KIM, JOO HANG, KIM, DAE JOON, CHO, BYOUNG CHUL
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2011
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440747/
https://ncbi.nlm.nih.gov/pubmed/22977560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.273
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller